About Neuromathix
Neuromathix is a Healthcare company based in Brisbane (Australia) founded in 2001 by Nigel Greenwood. It offers decision support software for personalized healthcare models based on patient data. It operates on a B2B model. Its chief executive is Nigel Greenwood. Its focus areas include HealthTech, Software Solutions and Personalized Medicine. Its competitors include AccuRx, MedAware, Archon Bio, Pyrls and YouScript and 4 more; 7 of its 9 listed competitors have raised funding.
Company details
Neuromathix, based in Brisbane, focuses on providing healthcare solutions, healthtech, providing software for education, and personalized medicine. Offers decision support software for personalized healthcare models based on patient data. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
- Headquarters Brisbane, Australia
- Founders Nigel Greenwood
- SectorsHealthcare
- Website neuromathix.com
- Social X
People of Neuromathix
1 people are tracked at Neuromathix (1 in leadership).
| Name | Role | Group |
|---|---|---|
Nigel Greenwood | Founder, CEO | Leadership |
Complete people profiles for Neuromathix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Neuromathix
Neuromathix has 9 listed competitors in our database, 7 of them funded. They include AccuRx, MedAware, Archon Bio, Pyrls and YouScript, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| accurx.com | 2016 | London, United Kingdom | $50M | 53 | Platform to increase antibiotic prescribing accuracy in primary care | |
| medaware.com | 2012 | Stamford, United States | $9M | – | Provider of an AI based medication dosage and safety managing software for healthcare professionals | |
| archon.bio | 2023 | Seattle, United States | $20M | – | Provider of computational platform to develop protein therapeutics | |
| pyrls.com | 2018 | Minneapolis, United States | $125,000 | – | Cloud-based practical drug information platform for providers | |
| youscript.com | 2000 | Seattle, United States | – | 14 | Clinical decision support software for drug interactions is developed. | |
| ameritox.com | 1996 | Baltimore, United States | – | – | Pain medication monitoring solutions are provided for US clinicians. | |
| bainbridgehealth.com | 2016 | Philadelphia, United States | $9.7M | 17 | Provider of a clinical intelligence data analytics platform to monitor patient safety and reduce medication errors | |
| betterfittechnologies.com | 2011 | Cambridge, United States | $1.09M | – | Offers an adaptive texting platform to monitor patient compliance in drug therapy. | |
| etcembly.io | 2020 | Harwell, United Kingdom | $12.66M | – | Provider of AI-based platform to engineer novel T cell receptors for cancer immunotherapy |
Detailed competitors of Neuromathix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Neuromathix (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Neuromathix
Neuromathix was founded in 2001.
Neuromathix is headquartered in Brisbane, Australia. It is registered at Brisbane, Queensland, Australia.
Nigel Greenwood is the current CEO of Neuromathix. They have also founded this company.
Neuromathix, based in Brisbane, focuses on providing healthcare solutions, healthtech, providing software for education, and personalized medicine. Offers decision support software for personalized healthcare models based on patient data. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
Neuromathix's top competitors include AccuRx, Etcembly and Archon Bio.